Development and validation of novel signature to predict overall survival in "driver-gene-negative" lung adenocarcinoma (LUAD): results of a multicenter studyCui, Yongmei; Fang, Wenfeng; Li, Chaofeng; Tang, Ke-Jing; Zhang, Jian; Lei, Yiyan; He, Weiling; Peng, Sui; Kuang, Ming; Zhang, Hui; Chen, Lili; Xu, Di; Tang, Cuilan; Zhang, Wenhui; Zhu, Yuxin; Jiang, Wenting; Jiang, Neng; Sun, Yu; Chen, Yangshan; Wang, Han; Lai, Yingrong; Li, Shuhua; He, Qiong; Zhou, Jianwen; Zhang, Yang; Lin, Millicent; Chen, Honglei; Zhou, Chengzhi; Wang, Chunlin; Wang, Jianhong; Zou, Xuenong; wang, Lian-tang; Ke, Zunfu · Clinical Cancer Research · 2018

The role of microRNAs in tumorsLiu, Chuanxin · Archives of Pharmacal Research · 2013

Antiangiogenic effects of cucurbitacin-IKim, Hyeon Jin; Kim, Jin-Kyung · Archives of Pharmacal Research · 2015

Integrating autophagy and metabolism in cancerCheong, Heesun · Archives of Pharmacal Research · 2015

Cancer metabolism: targeting cancer universalityKim, Soo-Youl · Archives of Pharmacal Research · 2015

Organelle-specific Hsp90 inhibitorsSeo, Young Ho · Archives of Pharmacal Research · 2015

Inflammatory fibroblasts in cancerLim, Hyesol; Moon, Aree · Archives of Pharmacal Research · 2016

Microbial transformation of naringenin derivativesXiao, Yina; Lee, Ik-Soo · Archives of Pharmacal Research · 2017

Peroxisomal dysfunction in neurodegenerative diseasesJo, Doo Sin; Cho, Dong-Hyung · Archives of Pharmacal Research · 2019